Tandem Diabetes Care Inc (TNDM)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 49.75% | 51.11% | 51.54% | 51.28% | 51.84% | 52.31% | 53.01% | 53.74% | 53.91% | 53.82% | 53.91% | 53.31% | 53.09% | 53.41% | 52.98% | 53.56% | 53.62% | 53.17% | 53.31% | 52.54% |
| Operating profit margin | -31.55% | -28.31% | -29.54% | -26.01% | -11.66% | -7.93% | -0.94% | 1.44% | 3.25% | 4.36% | 3.33% | 0.45% | -1.62% | -5.68% | -7.24% | -4.90% | -4.62% | -5.55% | -10.19% | -18.87% |
| Pretax margin | -29.81% | -26.89% | -28.24% | -25.34% | -11.66% | -8.34% | -1.63% | 0.63% | 2.28% | 3.32% | 1.10% | -5.02% | -7.40% | -11.74% | -10.83% | -4.16% | -6.79% | -7.15% | -20.01% | -53.05% |
| Net profit margin | -30.12% | -27.33% | -28.59% | -25.81% | -11.87% | -8.64% | -1.73% | 0.80% | 2.23% | 3.32% | 1.10% | -4.62% | -7.01% | -11.30% | -10.38% | -4.22% | -6.83% | -7.19% | -20.02% | -53.07% |
Tandem Diabetes Care Inc's profitability ratios have shown a declining trend over the past eight quarters. The gross profit margin has remained relatively stable, ranging from 49.17% to 51.54%. However, the operating profit margin has deteriorated significantly from -20.66% in Q4 2023 to -3.96% in Q3 2022 before turning negative again. This suggests that the company's operating expenses have been increasing faster than its gross profit.
Similarly, the pretax margin and net profit margin have also declined over the same period. The pretax margin decreased from -29.46% in Q4 2023 to -1.62% in Q2 2022, showing a persistent negative trend. The net profit margin followed a similar pattern, dropping from -29.77% in Q4 2023 to -1.72% in Q2 2022 before rebounding slightly.
Overall, Tandem Diabetes Care Inc's profitability ratios indicate a concerning trend of declining profitability and increasing losses. Further analysis of the company's cost structure, revenue generation, and operational efficiency may be needed to address the challenges impacting its profitability.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -24.48% | -22.98% | -24.50% | -21.52% | -8.82% | -5.95% | -0.69% | 1.04% | 2.50% | 3.36% | 2.50% | 0.32% | -1.11% | -3.64% | -4.78% | -5.62% | -5.13% | -6.26% | -10.98% | -18.70% |
| Return on assets (ROA) | -23.37% | -22.18% | -23.71% | -21.35% | -8.99% | -6.49% | -1.27% | 0.58% | 1.72% | 2.56% | 0.82% | -3.26% | -4.80% | -7.24% | -6.85% | -4.84% | -7.59% | -8.10% | -21.59% | -52.59% |
| Return on total capital | -38.96% | -36.08% | -37.81% | -32.99% | -12.84% | -8.85% | -0.97% | 1.47% | 3.17% | 4.26% | 3.17% | 0.40% | -1.40% | -4.66% | -6.36% | -9.31% | -8.58% | -10.96% | -19.27% | -33.19% |
| Return on equity (ROE) | -70.98% | -66.39% | -68.18% | -60.15% | -21.50% | -16.10% | -2.93% | 1.35% | 3.59% | 5.58% | 1.89% | -7.84% | -9.39% | -14.92% | -15.77% | -8.03% | -12.70% | -14.20% | -37.88% | -93.34% |
Tandem Diabetes Care Inc's profitability ratios paint a concerning picture of the company's performance over the analyzed periods. The Operating return on assets (Operating ROA) has been consistently negative, indicating that the company is not generating profits from its assets through its core operations. The Return on assets (ROA) also shows negative trends, reflecting the company's inability to generate earnings from its total assets. Additionally, the Return on total capital and Return on equity (ROE) ratios exhibit consistent negativity, highlighting that the company is not effectively utilizing its capital to generate returns for shareholders. These ratios collectively suggest that Tandem Diabetes Care Inc is facing significant challenges in profitability and operational efficiency, which could raise concerns for investors and stakeholders.